1 GL-1543a EDIT-long-road The Long Road to a New Medicine John H. (Wick) Johnson, Ph.D. Pfizer...

5
1 GL-1543a EDIT-long-road The Long Road to a New Medicine John H. (Wick) Johnson, Ph.D. Pfizer Global Research & Development Ann Arbor, Michigan

Transcript of 1 GL-1543a EDIT-long-road The Long Road to a New Medicine John H. (Wick) Johnson, Ph.D. Pfizer...

Page 1: 1 GL-1543a EDIT-long-road The Long Road to a New Medicine John H. (Wick) Johnson, Ph.D. Pfizer Global Research & Development Ann Arbor, Michigan.

1 GL-1543a

EDIT-long-road

The Long Road to a New Medicine

John H. (Wick) Johnson, Ph.D.Pfizer Global Research & Development

Ann Arbor, Michigan

Page 2: 1 GL-1543a EDIT-long-road The Long Road to a New Medicine John H. (Wick) Johnson, Ph.D. Pfizer Global Research & Development Ann Arbor, Michigan.

2 GL-1543a

EDIT-long-road

The Long Road to a New Medicine

Discovery

Exploratory Development

Full Development

Registration

Page 3: 1 GL-1543a EDIT-long-road The Long Road to a New Medicine John H. (Wick) Johnson, Ph.D. Pfizer Global Research & Development Ann Arbor, Michigan.

3 GL-1543a

EDIT-long-road

The Long Road to a New Medicine

Discovery

Exploratory Development

Registration

Full Development

Project Teamand Plans

Synthesisof Compounds

Screening

EarlySafety

Studies

Candidate

3 GL-1543a

Rev. 11/00

Page 4: 1 GL-1543a EDIT-long-road The Long Road to a New Medicine John H. (Wick) Johnson, Ph.D. Pfizer Global Research & Development Ann Arbor, Michigan.

4 GL-1543a

EDIT-long-road

The Long Road to a New Medicine

Large Amounts ofCandidate Medicine

Synthesized

Project Teamand Plans

Synthesisof Compounds

EarlySafety

Studies

CandidateFormulations

Developed

ExtensiveSafety

StudiesStudies in HealthyVolunteers Phase I

Discovery

Exploratory Development

Full Development

Registration

Screening

Page 5: 1 GL-1543a EDIT-long-road The Long Road to a New Medicine John H. (Wick) Johnson, Ph.D. Pfizer Global Research & Development Ann Arbor, Michigan.

5 GL-1543a

EDIT-long-road

The Long Road to a New Medicine

Discovery

Exploratory Development

Full Development

Registration

Large Amounts ofCandidate Medicine

Synthesized

Project Teamand Plans

Synthesisof Compounds

EarlySafety

Studies

CandidateFormulations

Developed

ExtensiveSafety

Studies

Screening

Studies in HealthyVolunteers Phase I

Candidate Medicine Tested in3-10,000 Patients (Phase III)

Studies in 100-300Patients (Phase II)

Clinical DataAnalysis

5GL-1543a

Rev. 11/00